Length of the menstrual cycle after discontinuation of oral contraceptives

REFERENCES

• Fraser IS, Weisberg E. Fertility following discontinuation of different methods of fertility control. Contraception 1982;26: 389–415.
   PubMedGoogle Scholar
• Huggins GR, Cullins VE. Fertility after contraception or abortion. Fertil Steril 1990;54:559–573.
   PubMed Web of Science ®Google Scholar
• Bell ET, Loraine JA. Urinary steroid and gonadotrophin excretion in women following long-term use of oral contra-ceptives. Lancet 1967;2:442–444.
   Google Scholar
• Klein TA, Mishell DR. Gonadotropin, prolactin, and steroid hormone levels after discontinuation of oral contraceptives. Am J Obstet Gynecol 1977;127:585–589.
   PubMed Web of Science ®Google Scholar
• Rice-Wray E, Correu S, Gorodovsky J, Esquivel J, Goldzieher JW. Return of ovulation after discontinuance of oral contra-ceptives. Fertil Steril 1967;18:212–218.
   Google Scholar
• Larsson-Cohn U. The length of the first three menstrual cycles after combined oral contraceptive treatment. Acta Cbstet Gynecol Scand 1969;48:416–422.
   PubMed Web of Science ®Google Scholar
• Coney P, DelConte A. The effects on ovarian activity of a monophasic oral contraceptive with 100 tig levonorgestrel and 20 tig ethinylestradiol. Am J Obstet Gynecol 1999;181: S53–S58.
   Google Scholar
• Lähteenmäki P, Ylöstalo P, Sipinen S, Toivonen J, Ruusu-vaara L, Pikkola P, Nilsson CG, Luukkainen T. Return of ovulation after abortion and after discontinuation of oral contraceptives. Fertil Steril 1980;34:246–249.
   PubMed Web of Science ®Google Scholar
• Spona J, Feichtinger W, Kindermann CH, Wtinsch C, Brill K. Inhibition of ovulation by an oral contraceptive containing 100 tig levonorgestrel in combination with 20 ttg ethinylestra-diol. Contraception 1996;54: 299–304.
   Google Scholar
• Elstein M, Morris SE, Groom GV, Jener DA, Scarisbrick JJ, Cameron EHD. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17#-ethinyl estradiol concentra-tions. Fertil Steril 1976;27:892–899.
   PubMed Web of Science ®Google Scholar
• Shaw G, Killick S, Elstein M. Assessment of ovarian activity in a gestodene containing triphasic oral contraceptive. Br J Fam Planning 1992;18:76–78.
   Google Scholar
• Gnoth C, Frank-Hermann P, Schmoll A, Godehardt E, Freundl G. Cycle characteristics after discontinuation of oral contraceptives. Gynecol Endocrinol 2002;16:307–317.
   PubMed Web of Science ®Google Scholar
• Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P. Omitting the first oral contra-ceptive pills of the cycle does not automatically lead to ovulation. Am J Obstet Gynecol 1998;179:41–46.
   Google Scholar
• Spellacy WN, Kalra PS, Buhi W, Birk SA. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive. Am J Obstet Gynecol 1980;137:109–115.
   Google Scholar
• Harlow SD, Ephross SA. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev 1995;17: 265–286.
   PubMed Web of Science ®Google Scholar
• Goldzieher JW. Pharmacology of contraceptive steroids: a brief review. Am J Obstet Gynecol 1989;160:1260–1264.
   PubMed Web of Science ®Google Scholar
• Tauber U, Tack JW, Matthes H. Single dose pharmacoki-netics of gestodene in women after intravenous and oral administration. Contraception 1989;40:461–479.
   Google Scholar
• Van der Spuy ZM, Sohnius U, Pienaar CA, Schall R. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. Contraception 1990;42:597–609.
   PubMed Web of Science ®Google Scholar
• Van Heusden AM, Fauser BCJM. Activity of the pituitary—ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. Contraception 1999;59:237–243.
   PubMed Web of Science ®Google Scholar
• Van Heusden AM, Coelingh Bennink HJT, Fauser BCJM. FSH and ovarian response: spontaneous recovery of pituitary—ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contra-ceptives. Chin Endocrinol 2002;56:509–517.
   Google Scholar
• Van Santbrink EJP, Hop WC, van Dessel TJHM, de Jong FH, Fauser BCJM. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril 1995;64:37–43.
   Google Scholar
• Yu A-F, Wu S-X, Liu J-L, Liu A-R, Li J-Z, Wu J-H, Hu Z-Z, Yin B-Y, Xu G-X, Fotherby E. Metabolic changes in women using a long-acting monthly oral contraceptive and return of ovulation on discontinuation. Contraception 1988;37:517–528.
   Google Scholar